News & Events :: SCYNEXIS, Inc. (SCYX)

Skip to main content Skip to section navigation Skip to footer

Recent News

Jun 30, 2026 8:00am EDT

SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

May 22, 2026 4:15pm EDT

SCYNEXIS Announces One-for-Eight Reverse Stock Split

Recent Events

View All Events

Jun 25, 2026 9:30 am EDT

2026 Annual Meeting of Stockholders

May 19, 2026 9:30 am EDT

Special Meeting of Stockholders

View All Events

Latest Presentation

View All Presentations

Mar 31, 2026

Investor Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings